Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | PRKCA | P17252 | 5/20 | 0.55 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.55 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.55 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | FAAH | O00519 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 1/20 | 0.54 |
| ▸ | CNR2 | P34972 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8973706 | 0.91 | MAPT (0.60) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL8947469 | 0.87 | MAPT (0.56) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL2927505 | 0.86 | PRKCA (0.75) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL77143 | 0.86 | PRKCA (0.75) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL13901278 | 0.85 | MAPT (0.61) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL380541 | 0.85 | MAPT (0.96) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL2719944 | 0.83 | ALDH1A1 (0.52) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL723509 | 0.83 | MAPT (1.00) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL239865 | 0.83 | MAPT (1.00) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL2507783 | 0.83 | MAPT (1.00) | MAPTMAPK1PRKCAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 762 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113198408-B | System and method for effectively promoting esterification reaction | 唐河金海生物科技有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119817712-A | Microemulsion composition and preparation and application thereof | 龙岩新奥生物科技有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119679054-A | Lactating sow feed and preparation method thereof | 广东加大实业有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-119366588-A | Feed containing short-medium chain fatty glyceride feed additive and preparation method thereof | 湖北浩华生物技术有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-118645606-B | Sodium ion battery anode nano material and application thereof in vehicle | 浙江华宇钠电新能源科技有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-119140038-A | Device and method for preparing monobutyralte | 山东成武易信环保科技有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-118460119-B | Chemical mechanical polishing liquid, application thereof and chemical mechanical polishing method | 万华化学集团电子材料有限公司 | 2024-10-18 | — | — | CN | claimed |
| CN-118725528-A | Fully-degradable mulching film capable of blocking weeds and preparation method thereof | 成都蓉橙九天生物科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-118645606-A | Sodium ion battery anode nano material and application thereof in vehicle | 浙江华宇钠电新能源科技有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-118599306-A | Flame-retardant material for power supply connector | 中山市龙正塑料五金制品有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-106632393-B | The preparation method for the treatment of tuberculosis drug candidate PA-824 | 荆楚理工学院 | 2018-08-14 | — | — | CN | claimed |
| CN-105746905-A | Feed additive and preparation method thereof | 湖南晶天科技实业有限公司 | 2016-07-13 | — | — | CN | claimed |
| EP-2938331-A1 | SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF CATIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Chong Kun Dang Pharmaceutical Corp. (KR) | 2015-11-04 | — | — | EP | claimed |
| EP-2938333-A1 | SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF ANIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Chong Kun Dang Pharmaceutical Corp. (KR) | 2015-11-04 | — | — | EP | claimed |
| US-20150290322-A1 | SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF ANIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2015-10-15 | — | — | US | claimed |
| US-20150265535-A1 | SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF CATIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2015-09-24 | — | — | US | claimed |
| WO-2014104784-A4 | SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF CATIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2014-07-31 | — | — | WO | claimed |
| WO-2014104784-A1 | SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF CATIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2014-07-03 | — | — | WO | claimed |
| WO-2014104788-A1 | SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF ANIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2014-07-03 | — | — | WO | claimed |
| US-20080213341-A1 | Butyric Acid Esters of Carbohydrates and Carbohydrate Polyols | SUDZUCKER AKTIENGESELLSCHAFT MANNHEIM/OCHSENFURT (DE) | 2008-09-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150290322-A1 | SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF ANIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | ORAI1, LIPC, LIPA | MAPT 701/4885MAPK1 2760/4885PRKCA 2730/4885 |
| US-20150265535-A1 | SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF CATIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | SLC27A1, ORAI1, LIPA | MAPT 1979/4885MAPK1 3082/4885PRKCA 3012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.